United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2004_register executive 2010-09-22 article Notices D09002ee1c815cbe9 D09002ee1c815cc92 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration (FDA) is reopening until August 10, 2004, the comment period for the draft guidances entitled "Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements," "Help-Seeking and Other Disease Awareness Communications by or on Behalf of Drug and Device Firms," and "Consumer-Directed Broadcast Advertising of Restricted Devices." FDA published a notice of availability of the draft guidances in the Federal Register of February 10, 2004 (69 FR 6308). FDA is taking this action in response to requests for an extension and to allow interested parties additional time to submit comments. 69 FR 30945 https://www.govinfo.gov/app/details/FR-2004-06-01/04-12270 04-12270 fr01jn04-109 4160-01-S Docket No. 2004D-0042 https://www.govinfo.gov/app/details/FR-2004-06-01/04-12270 https://www.govinfo.gov/content/pkg/FR-2004-06-01/html/04-12270.htm https://www.govinfo.gov/content/pkg/FR-2004-06-01/pdf/04-12270.pdf 1 p. 30945 30945 69 FR 30945 Draft Guidances for Industry on Improving Information About Medical Products and Health Conditions; Availability; Reopening of Comment Period; Federal Register Vol. 69, Issue NOTICE 04-12270 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 2004-08-10 Docket No. 2004D-0042 4160-01-S 04-12270 Notice; reopening of comment period.

The Food and Drug Administration (FDA) is reopening until August 10, 2004, the comment period for the draft guidances entitled "Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements," "Help-Seeking and Other Disease Awareness Communications by or on Behalf of Drug and Device Firms," and "Consumer-Directed Broadcast Advertising of Restricted Devices." FDA published a notice of availability of the draft guidances in the Federal Register of February 10, 2004 (69 FR 6308). FDA is taking this action in response to requests for an extension and to allow interested parties additional time to submit comments.

Submit written or electronic comments on the draft guidances by August 10, 2004. General comments on agency guidance documents are welcome at any time. Regarding prescription human drugs: Lesley R. Frank, Center for Drug Evaluation and Research (HFD-42), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-2831. Reports and guidance documents; availability, etc.: Medical devices Medical products and health conditions; information improvement, http://ww.fda.gov/ohrms/dockets/default.htm http://www.fda.gov/cber/guidelines http://www.fda.gov/cder/guidance/index.htm Vol. 69, no. 105 Office of the Federal Register, National Archives and Records Administration 2004-06-01 continuing daily deposited born digital 196 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2004-06-01 P0b002ee18096b113 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr01jn04 https://www.govinfo.gov/app/details/FR-2004-06-01 https://www.govinfo.gov/content/pkg/FR-2004-06-01/pdf/FR-2004-06-01.pdf https://www.govinfo.gov/content/pkg/FR-2004-06-01/xml/FR-2004-06-01.xml fdlp 30815 30995 DGPO 2010-09-22 2024-06-06 FR-2004-06-01 machine generated eng FR FR-2004-06-01 69 105